Cirrus Logic Inc. (CRUS) Has Climbed To A 3-Month High
Cirrus Logic Inc. (CRUS) has been rising steadily since the open of trade Monday and is now up 3.44 at $41.04.
Source: RTTNews
FDA Approves Aurinia Pharmaceuticals' (Nasdaq: AUPH / TSX: AUP) LUPKYNIS (voclosporin) for Adult Patients with Active Lupus Nephritis




